XML 31 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of Common Stock Shares Activity

The following table summarizes common stock share activity for the three months ended March 31, 2024 and 2023 (dollars in thousands):

 

 

 

Three Months Ended March 31, 2024

 

 

 

Shares of
Common Stock

 

 

Common
Stock

 

 

Additional
Paid-in
Capital

 

 

Accumulated
Deficit

 

 

Total
Stockholders’ Equity

 

Balance, December 31, 2023

 

 

37,207,799

 

 

$

40

 

 

$

428,169

 

 

$

(355,247

)

 

$

72,962

 

Net income

 

 

 

 

 

 

 

 

 

 

 

411

 

 

 

411

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

705

 

 

 

 

 

 

705

 

Common stock issued through employee stock purchase plan

 

 

18,815

 

 

 

 

 

 

26

 

 

 

 

 

 

26

 

Common stock issued for vested restricted stock units

 

 

553,182

 

 

 

1

 

 

 

 

 

 

 

 

 

1

 

Balance, March 31, 2024

 

 

37,779,796

 

 

$

41

 

 

$

428,900

 

 

$

(354,836

)

 

$

74,105

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2023

 

 

 

Shares of
Common Stock

 

 

Common
Stock

 

 

Additional
Paid-in
Capital

 

 

Accumulated
Deficit

 

 

Total
Stockholders’
(Deficit) Equity

 

Balance, December 31, 2022

 

 

32,682,342

 

 

$

36

 

 

$

425,485

 

 

$

(422,288

)

 

$

3,233

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(33,876

)

 

 

(33,876

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

707

 

 

 

 

 

 

707

 

Common stock issued through employee stock purchase plan

 

 

2,662

 

 

 

 

 

 

4

 

 

 

 

 

 

4

 

Common stock issued, net of expenses

 

 

363,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for vested restricted stock units

 

 

279,623

 

 

 

 

 

 

18

 

 

 

 

 

 

18

 

Balance, March 31, 2023

 

 

33,327,627

 

 

$

36

 

 

$

426,214

 

 

$

(456,164

)

 

$

(29,914

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock Reserved For Future Issuances

The Company had reserved shares of common stock for future issuance as follows:

 

 

 

March 31, 2024

 

 

December 31, 2023

 

Outstanding stock options

 

 

2,716,602

 

 

 

1,867,795

 

Outstanding restricted stock units

 

 

3,202,012

 

 

 

1,886,374

 

Warrants to purchase common stock associated with December 2020 public offering - Series 2

 

 

6,800,000

 

 

 

6,800,000

 

Prefunded warrants to purchase common stock associated with December 2020 public offering

 

 

3,200,000

 

 

 

3,200,000

 

Warrants to purchase common stock associated with April 2022 public offering

 

 

15,000,000

 

 

 

15,000,000

 

Prefunded warrants to purchase common stock associated with April 2022 public offering

 

 

7,516,267

 

 

 

7,516,267

 

Warrants to purchase common stock associated with Loan Agreement

 

 

198,811

 

 

 

198,811

 

Warrant to purchase common stock associated with Danforth

 

 

50,000

 

 

 

50,000

 

For possible future issuance for the conversion of the March 2019 Notes

 

 

1,138,200

 

 

 

1,138,200

 

For possible future issuance under 2014 Plan (Note 9)

 

 

 

 

 

848,202

 

For possible future issuance under employee stock purchase plan

 

 

1,458,171

 

 

 

1,474,045

 

For possible future issuance under 2015 Plan (Note 9)

 

 

637,050

 

 

 

633,590

 

Total common shares reserved for future issuance

 

 

41,917,113

 

 

 

40,613,284